Live from the NIH registry
Studies recruiting near Bakersfield right now
Top 25 of 67 recruiting studies, sorted by proximity — each links to its official registry page
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Kern Research, Inc.- Site Number : 8400047 — Bakersfield, California (1.7 mi)
· Sponsor: Sanofi
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
Non-Muscle Invasive Bladder Cancer
Phase 1, Phase 2
Interventional 32 participants sought
Michael G Oefelein Clinical Trials ( Site 0053) — Bakersfield, California (1.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
California Retina Consultants-Bakersfield-65523 — Bakersfield, California (1.7 mi)
· Sponsor: Boehringer Ingelheim
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Non-small Cell Lung Cancer
Phase 3
Interventional 600 participants sought
CBCC Global Research, Inc. ( Site 0123) — Bakersfield, California (1.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Phase 2
Interventional 15 participants sought
Adverum site 109 — Bakersfield, California (1.7 mi)
· Sponsor: Adverum Biotechnologies, Inc.
Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout
Burnout, Burnout Syndrome
N/A
Interventional 203 participants sought
Bakersfield VA Clinic, VA Greater Los Angeles Healthcare System — Bakersfield, California (1.7 mi)
· Sponsor: VA Greater Los Angeles Healthcare System
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Retinitis Pigmentosa
Phase 2
Interventional 60 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: jCyte, Inc
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Chronic Inducible Urticaria, Cold Urticaria
Phase 3
Interventional 240 participants sought
Kern Research, Inc. — Bakersfield, California (1.7 mi)
· Sponsor: Celldex Therapeutics
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Phase 3
Interventional 700 participants sought
CBCC Global Research — Bakersfield, California (1.7 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Non-muscle-invasive Bladder Cancer
Phase 1, Phase 2
Interventional 75 participants sought
Unio Specialty Care - A Genesis Healthcare Partners Facility — Bakersfield, California (1.7 mi)
· Sponsor: SURGE Therapeutics
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Diabetic Macular Edema, DME
Phase 3
Interventional 240 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: EyePoint Pharmaceuticals, Inc.
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Phase 3
Interventional 454 participants sought
Michael G Oefelein, MD Clinical Trials — Bakersfield, California (1.7 mi)
· Sponsor: Ferring Pharmaceuticals
A Study in Adults With Geographic Atrophy
Geographic Atrophy
Phase 2
Interventional 300 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: Sitala Bio LTD
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Adventist Health - Bakersfield — Bakersfield, California (1.7 mi)
· Sponsor: Agendia
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Non-Muscle Invasive Bladder Urothelial Carcinoma, Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma
Phase 2
Interventional 160 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Melanoma Stage IV, Solid Tumor
Phase 1, Phase 2
Interventional 117 participants sought
Comprehensive Blood and Cancer Center — Bakersfield, California (1.7 mi)
· Sponsor: Georgiamune Inc
Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial
Kidney Calculi; Ureteral Calculi
N/A
Interventional 101 participants sought
Michael G. Oefelein Clinical Trials — Bakersfield, California (1.7 mi)
· Sponsor: Avvio Medical
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Breast Cancer, Metastatic Breast Cancer
Phase 3
Interventional 404 participants sought
Comprehensive Blood and Cancer Center — Bakersfield, California (1.7 mi)
· Sponsor: BriaCell Therapeutics Corporation
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
California Retina Consultants (CRC) - Bakersfield Office — Bakersfield, California (1.7 mi)
· Sponsor: Apellis Pharmaceuticals, Inc.
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
HIV Infections
Phase 2
Interventional 186 participants sought
GSK Investigational Site — Bakersfield, California (1.7 mi)
· Sponsor: ViiV Healthcare
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
AMD, nAMD
Phase 3
Interventional 714 participants sought
California Retina Consultants - Bakersfield /ID# 256240 — Bakersfield, California (1.7 mi)
· Sponsor: AbbVie
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Bladder (Urothelial, Transitional Cell) Cancer, Non-Muscle Invasive Bladder Carcinoma
Phase 3
Interventional 284 participants sought
Michael Oefelein Clinical Trials — Bakersfield, California (1.7 mi)
· Sponsor: Protara Therapeutics
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
ADARx Clinical Site — Bakersfield, California (1.7 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
Solid Tumor
Phase 1, Phase 2
Interventional 100 participants sought
CBCC Global Research Site 005 — Bakersfield, California (1.7 mi)
· Sponsor: Alyssum Therapeutics